Cargando…

Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI

BACKGROUND: Advanced lung cancer inflammation index (ALI, body mass index [BMI] x serum albumin/neutrophil-lymphocyte ratio [NLR]) has been shown to predict overall survival (OS) in small cell lung cancer (SCLC). CT enables skeletal muscle to be quantified, whereas BMI cannot accurately reflect body...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Eun Young, Kim, Nambeom, Kim, Young Saing, Seo, Ja-Young, Park, Inkeun, Ahn, Hee Kyung, Jeong, Yu Mi, Kim, Jeong Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051688/
https://www.ncbi.nlm.nih.gov/pubmed/27706243
http://dx.doi.org/10.1371/journal.pone.0164056
_version_ 1782458125580763136
author Kim, Eun Young
Kim, Nambeom
Kim, Young Saing
Seo, Ja-Young
Park, Inkeun
Ahn, Hee Kyung
Jeong, Yu Mi
Kim, Jeong Ho
author_facet Kim, Eun Young
Kim, Nambeom
Kim, Young Saing
Seo, Ja-Young
Park, Inkeun
Ahn, Hee Kyung
Jeong, Yu Mi
Kim, Jeong Ho
author_sort Kim, Eun Young
collection PubMed
description BACKGROUND: Advanced lung cancer inflammation index (ALI, body mass index [BMI] x serum albumin/neutrophil-lymphocyte ratio [NLR]) has been shown to predict overall survival (OS) in small cell lung cancer (SCLC). CT enables skeletal muscle to be quantified, whereas BMI cannot accurately reflect body composition. The purpose was to evaluate prognostic value of modified ALI (mALI) using CT-determined L3 muscle index (L3MI, muscle area at L3/height(2)) beyond original ALI. METHODS: L3MIs were calculated using the CT images of 186 consecutive patients with SCLC taken at diagnosis, and mALI was defined as L3MI x serum albumin/NLR. Using chi-squared test determined maximum cut-offs for low ALI and low mALI, the prognostic values of low ALI and low mALI were tested using Kaplan-Meier method and Cox proportional hazards analysis. Finally, deviance statistics was used to test whether the goodness of fit of the prognostic model is improved by adding mALI as an extra variable. RESULTS: Patients with low ALI (cut-off, 31.1, n = 94) had shorter OS than patients with high ALI (median, 6.8 months vs. 15.8 months; p < 0.001), and patients with low mALI (cut-off 67.7, n = 94) had shorter OS than patients with high mALI (median, 6.8 months vs. 16.5 months; p < 0.001). There was no significant difference in estimates of median survival time between low ALI and low mALI (z = 0.000, p = 1.000) and between high ALI and high mALI (z = 0.330, p = 0.740). Multivariable analysis showed that low ALI was an independent prognostic factor for shorter OS (HR, 1.67, p = 0.004), along with advanced age (HR, 1.49, p = 0.045), extensive disease (HR, 2.27, p < 0.001), supportive care only (HR, 7.86, p < 0.001), and elevated LDH (HR, 1.45, p = 0.037). Furthermore, goodness of fit of this prognostic model was not significantly increased by adding mALI as an extra variable (LR difference = 2.220, p = 0.136). CONCLUSION: The present study confirms mALI using CT-determined L3MI has no additional prognostic value beyond original ALI using BMI. ALI is a simple and useful prognostic indicator in SCLC.
format Online
Article
Text
id pubmed-5051688
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-50516882016-10-27 Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI Kim, Eun Young Kim, Nambeom Kim, Young Saing Seo, Ja-Young Park, Inkeun Ahn, Hee Kyung Jeong, Yu Mi Kim, Jeong Ho PLoS One Research Article BACKGROUND: Advanced lung cancer inflammation index (ALI, body mass index [BMI] x serum albumin/neutrophil-lymphocyte ratio [NLR]) has been shown to predict overall survival (OS) in small cell lung cancer (SCLC). CT enables skeletal muscle to be quantified, whereas BMI cannot accurately reflect body composition. The purpose was to evaluate prognostic value of modified ALI (mALI) using CT-determined L3 muscle index (L3MI, muscle area at L3/height(2)) beyond original ALI. METHODS: L3MIs were calculated using the CT images of 186 consecutive patients with SCLC taken at diagnosis, and mALI was defined as L3MI x serum albumin/NLR. Using chi-squared test determined maximum cut-offs for low ALI and low mALI, the prognostic values of low ALI and low mALI were tested using Kaplan-Meier method and Cox proportional hazards analysis. Finally, deviance statistics was used to test whether the goodness of fit of the prognostic model is improved by adding mALI as an extra variable. RESULTS: Patients with low ALI (cut-off, 31.1, n = 94) had shorter OS than patients with high ALI (median, 6.8 months vs. 15.8 months; p < 0.001), and patients with low mALI (cut-off 67.7, n = 94) had shorter OS than patients with high mALI (median, 6.8 months vs. 16.5 months; p < 0.001). There was no significant difference in estimates of median survival time between low ALI and low mALI (z = 0.000, p = 1.000) and between high ALI and high mALI (z = 0.330, p = 0.740). Multivariable analysis showed that low ALI was an independent prognostic factor for shorter OS (HR, 1.67, p = 0.004), along with advanced age (HR, 1.49, p = 0.045), extensive disease (HR, 2.27, p < 0.001), supportive care only (HR, 7.86, p < 0.001), and elevated LDH (HR, 1.45, p = 0.037). Furthermore, goodness of fit of this prognostic model was not significantly increased by adding mALI as an extra variable (LR difference = 2.220, p = 0.136). CONCLUSION: The present study confirms mALI using CT-determined L3MI has no additional prognostic value beyond original ALI using BMI. ALI is a simple and useful prognostic indicator in SCLC. Public Library of Science 2016-10-05 /pmc/articles/PMC5051688/ /pubmed/27706243 http://dx.doi.org/10.1371/journal.pone.0164056 Text en © 2016 Kim et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Kim, Eun Young
Kim, Nambeom
Kim, Young Saing
Seo, Ja-Young
Park, Inkeun
Ahn, Hee Kyung
Jeong, Yu Mi
Kim, Jeong Ho
Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI
title Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI
title_full Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI
title_fullStr Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI
title_full_unstemmed Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI
title_short Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI
title_sort prognostic significance of modified advanced lung cancer inflammation index (ali) in patients with small cell lung cancer_ comparison with original ali
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051688/
https://www.ncbi.nlm.nih.gov/pubmed/27706243
http://dx.doi.org/10.1371/journal.pone.0164056
work_keys_str_mv AT kimeunyoung prognosticsignificanceofmodifiedadvancedlungcancerinflammationindexaliinpatientswithsmallcelllungcancercomparisonwithoriginalali
AT kimnambeom prognosticsignificanceofmodifiedadvancedlungcancerinflammationindexaliinpatientswithsmallcelllungcancercomparisonwithoriginalali
AT kimyoungsaing prognosticsignificanceofmodifiedadvancedlungcancerinflammationindexaliinpatientswithsmallcelllungcancercomparisonwithoriginalali
AT seojayoung prognosticsignificanceofmodifiedadvancedlungcancerinflammationindexaliinpatientswithsmallcelllungcancercomparisonwithoriginalali
AT parkinkeun prognosticsignificanceofmodifiedadvancedlungcancerinflammationindexaliinpatientswithsmallcelllungcancercomparisonwithoriginalali
AT ahnheekyung prognosticsignificanceofmodifiedadvancedlungcancerinflammationindexaliinpatientswithsmallcelllungcancercomparisonwithoriginalali
AT jeongyumi prognosticsignificanceofmodifiedadvancedlungcancerinflammationindexaliinpatientswithsmallcelllungcancercomparisonwithoriginalali
AT kimjeongho prognosticsignificanceofmodifiedadvancedlungcancerinflammationindexaliinpatientswithsmallcelllungcancercomparisonwithoriginalali